DK336485A - Fremgangsmaade til fremstilling af et diisopropylaetersolvat af beclomethason-17,21-dipropionat - Google Patents

Fremgangsmaade til fremstilling af et diisopropylaetersolvat af beclomethason-17,21-dipropionat Download PDF

Info

Publication number
DK336485A
DK336485A DK336485A DK336485A DK336485A DK 336485 A DK336485 A DK 336485A DK 336485 A DK336485 A DK 336485A DK 336485 A DK336485 A DK 336485A DK 336485 A DK336485 A DK 336485A
Authority
DK
Denmark
Prior art keywords
beclomethason
diisopropylether
dipropionate
solvate
preparing
Prior art date
Application number
DK336485A
Other languages
English (en)
Other versions
DK336485D0 (da
Inventor
Philip Ronald Page
William Heggie
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PT7897284A external-priority patent/PT78972A/pt
Priority claimed from PT8079685A external-priority patent/PT80796B/pt
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Publication of DK336485D0 publication Critical patent/DK336485D0/da
Publication of DK336485A publication Critical patent/DK336485A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Saccharide Compounds (AREA)
DK336485A 1984-07-25 1985-07-24 Fremgangsmaade til fremstilling af et diisopropylaetersolvat af beclomethason-17,21-dipropionat DK336485A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT7897284A PT78972A (en) 1984-07-25 1984-07-25 Preparation process of a 17,21-dipropionate beclomethasona di-isopropylic ether solution and its utilization
PT8079685A PT80796B (pt) 1985-07-11 1985-07-11 Processo para a preparacao de solvatos etoericos de beclometasona 17,21-dipropionato e utilizacao dos mesmos

Publications (2)

Publication Number Publication Date
DK336485D0 DK336485D0 (da) 1985-07-24
DK336485A true DK336485A (da) 1986-01-26

Family

ID=26653439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK336485A DK336485A (da) 1984-07-25 1985-07-24 Fremgangsmaade til fremstilling af et diisopropylaetersolvat af beclomethason-17,21-dipropionat

Country Status (12)

Country Link
US (1) US4913892A (da)
EP (1) EP0172672B1 (da)
KR (1) KR880001237B1 (da)
AU (1) AU566318B2 (da)
CA (1) CA1274503A (da)
DE (1) DE3561321D1 (da)
DK (1) DK336485A (da)
HK (1) HK58789A (da)
IE (1) IE59086B1 (da)
IL (1) IL75903A (da)
NO (1) NO163899C (da)
NZ (1) NZ212877A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
MX9304585A (es) 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
CN1245982C (zh) 1996-05-09 2006-03-22 阿姆瑞德手术有限公司 哮喘和气道疾病的治疗
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
EP0039369B1 (en) * 1980-05-02 1983-06-15 Schering Corporation Beclomethasone ester solvates, process for their preparation, and preparation of a formulation
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it

Also Published As

Publication number Publication date
IL75903A (en) 1989-10-31
EP0172672B1 (en) 1988-01-07
NZ212877A (en) 1988-03-30
EP0172672A1 (en) 1986-02-26
NO852948L (no) 1986-01-27
NO163899B (no) 1990-04-30
DK336485D0 (da) 1985-07-24
DE3561321D1 (en) 1988-02-11
AU4530585A (en) 1986-01-30
KR860001122A (ko) 1986-02-22
AU566318B2 (en) 1987-10-15
IE59086B1 (en) 1994-01-12
NO163899C (no) 1990-08-08
US4913892A (en) 1990-04-03
IL75903A0 (en) 1985-12-31
KR880001237B1 (ko) 1988-07-12
HK58789A (en) 1989-07-28
CA1274503A (en) 1990-09-25

Similar Documents

Publication Publication Date Title
DK162647C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK301986D0 (da) Fremgangsmaade til fremstilling af 1-hydroxyvitamin-d-forbindelser
DK162580C (da) Fremgangsmaade til fremstilling af mikrokapsler
DK583385D0 (da) Fremgangsmaade til fremstilling af et stabilt nicorandilpraeparat
DK154282A (da) Fremgangsmaade til fremstilling af et varmeisoleret ledningsroer
DK174383D0 (da) Fremgangsmade til fremstilling af et phenylalkylaminoethylsalicylamid
DK336485D0 (da) Fremgangsmaade til fremstilling af et diisopropylaetersolvat af beclomethason-17,21-dipropionat
DK1584A (da) Fremgangsmaade til fremstilling af et gitterkernesandwichelement
DK453080A (da) Fremgangsmaade til fremstilling af et depllymeriserende enzym
DK160829C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK156085A (da) Fremgangsmaade til fremstilling af acetoxyazetidinoner
DK73186A (da) Fremgangsmaade til fremstilling af et varmeisoleret ledningsroer
DK294584D0 (da) Fremgangsmaade til fremstilling af formparter
DK161706C (da) Fremgangsmaade til fremstilling af pyrido-imidazo-rifamyciner
DK455685A (da) Fremgangsmaade til fremstilling af cinnamatestere
DK304185A (da) Fremgangsmaade til fremstilling af furanon
DK161705C (da) Fremgangsmaade til fremstilling af et 13-hydroxy-5-ketomilbemycinderivat
DK295885A (da) Fremgangsmaade til fremstilling af 1-azidoaldoser
DK329685D0 (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalaninalkylestere
DK546088A (da) Fremgangsmaade til fremstilling af dimethylaminomethylkobberphthalocyanin
DK12494A (da) Fremgangsmaade til fremstilling af et forbindelsessted til varmeisolerede ledningsroer
DK18985D0 (da) Fremgangsmaade til fremstilling af et farmakologisk virksomt sulfonylurinstofderivat
DK229986A (da) Fremgangsmaade til fremstilling af 2-thiocromenylidenethylacetoacetater
DK40284A (da) Fremgangsmaade til fremstilling af n-phosphonmethylglycin
DK521885A (da) Fremgangsmaade til fremstilling af benzopyranotriazoler

Legal Events

Date Code Title Description
ATS Application withdrawn